01952

21.7605.23%
WL

Wenjun Liu

Co-President & Chief Commercial Officer

Mr. Wenjun Liu is Co-President & Chief Commercial Officer of Everest Medicines Limited from March 1, 2026. Mr. Liu started his business at MSD, where he was honored with various National Top Sales awards and received special approval for early promotion. Subsequently, he joined Hengrui Medicine. Over nearly a decade, he achieved rapid advancement, progressing from sales office supervisor to District Manager, Province Manager, Regional Director and ultimately to Deputy General Manager of Hengrui Integrated Business Division and Head of the Metabolism & Pain Franchise, becoming the youngest senior commercial leader of the enterprise. During this period, Mr. Liu delivered numerous outstanding achievements, including establishing brand influence in the metabolism and endocrinology field, elevating the market share of diabetes to second place nationwide among comparable products, driving a threefold increase in sales of innovative products and achieving significant breakthroughs in market access. Simultaneously, he successfully built a highly collaborative and cohesive professional team. Since September 2025, he has served as Chief Executive Officer and General Manager of Hasten. Mr. Liu holds a bachelor’s degree from China Pharmaceutical University.

Positions